Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
0 hedge funds and large institutions have $0 invested in Ampio Pharmaceuticals Inc. in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 6 closing their positions.
100% less funds holding
Funds holding: 6 → 0 (-6)
100% less capital invested
Capital invested by funds: $13 → $0 (-$13)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$10 |
| 2 |
SWM
Sanctuary Wealth Management
Pocatello,
Idaho
|
-$2 |
| 3 |
CTB
Country Trust Bank
Bloomington,
Illinois
|
-$1 |
AMPE Hedge Fund Activity: Q3 2024 in Review
0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2024, worth a combined $0 — down 100% from $13 a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of AMPE and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Osaic Holdings, exiting entirely with an estimated $10 sold.
- 0 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2024, down from 6 in Q2 2024.
- Funds reported $0 of Ampio Pharmaceuticals Inc. stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2024 and 6 closed out, a net change of -6 holders.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2024 was Osaic Holdings, an estimated $10 sold.
Based on aggregated 13F filings for Q3 2024.